Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM3 | P20309 | 8/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | NTRK1 | P04629 | 3/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.39 |
| ▸ | ACLY | P53396 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4914108 | 0.94 | CHRM3 (0.49) | CHRM3LMNAPOLBNTRK1TDP1 | |
| SCHEMBL4918647 | 0.92 | NTRK1 (0.47) | CHRM3LMNAPOLBNTRK1TDP1 | |
| SCHEMBL4914980 | 0.92 | LMNA (0.47) | CHRM3LMNAPOLBNTRK1TDP1 | |
| SCHEMBL4920459 | 0.88 | LMNA (0.51) | CHRM3LMNAPOLBNTRK1TDP1 | |
| SCHEMBL1086049 | 0.87 | NTRK1 (0.45) | CHRM3LMNAPOLBNTRK1MAPK1 | |
| SCHEMBL4919227 | 0.86 | NTRK1 (0.47) | CHRM3LMNAPOLBNTRK1TDP1 | |
| SCHEMBL2350381 | 0.86 | LMNA (0.47) | CHRM3LMNAPOLBNTRK1TDP1 | |
| SCHEMBL2346206 | 0.86 | CHRM3 (0.51) | CHRM3NTRK1TDP1MAPK1ATM | |
| SCHEMBL10238277 | 0.86 | CHRM3 (0.52) | CHRM3LMNANTRK1TDP1ATM | |
| SCHEMBL2341630 | 0.86 | ATM (0.56) | CHRM3NTRK1TDP1ATMCHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080153707-A1 | Pyrazolecarboxanilides, Process for Their Preparation and Compositions Comprising Them for Controlling Harmful Fungi | BASF AKITENGESELLSCHAFT (DE) | 2008-06-26 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080153707-A1 | Pyrazolecarboxanilides, Process for Their Preparation and Compositions Comprising Them for Controlling Harmful Fungi | CBR3, C1S, PYM1 | CHRM3 222/4885LMNA 1073/4885POLB 2358/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.